AKR1C1 and neoplasm: Moreover, the AKR1C1+ inflammatory fibroblast strongly expresses IL6 which interacts with IL6R expressed on DC1 and PRR-induced mo-DC, potentially contributing to tumor growth and therapeutic resistance36,37.